Imidazole → (S)-Benzyl 3-[tert-butyldimethylsilyloxy]glutaramate

HRID 921495Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 921495
[CH2:1]([O:8][C:9](=[O:17])[CH2:10][C@@H:11]([OH:16])[CH2:12][C:13]([NH2:15])=[O:14])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.N1C=CN=C1.[Si:23](Cl)([C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:25])[CH3:24]>CN(C)C=O>[CH2:1]([O:8][C:9](=[O:17])[CH2:10][C@@H:11]([O:16][Si:23]([C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:25])[CH3:24])[CH2:12][C:13]([NH2:15])=[O:14])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
5 °C

Versuchsvorschrift

(S)-Benzyl-3-hydroxyglutaramate (100 g) was dissolved in dimethyl formamide. To this Imidazole (35 g) was added and the solution was cooled to 5° C. To this a solution of tert-butyldimethylsilylchloride (68.5 g) dissolved in dimethyl formamide (250 ml) was added under cooling. The mixture was warmed to 20-25° C. and stirred. The reaction mixture was cooled and quenched with water. To the reaction mixture ethyl acetate and water was added and stirred. The layers were separated and the organic phase was washed thrice with water. The organic phase was evaporated under reduced pressure to yield (S)-benzyl-3-(tert-butyl dimethylsilyloxy)glutaramate as oil.

Aufarbeitung

  1. additionwas added
  2. temperatureunder cooling
  3. temperatureThe mixture was warmed to 20-25° C.
  4. temperatureThe reaction mixture was cooled
  5. customquenched with water
  6. additionTo the reaction mixture ethyl acetate and water was added
  7. stirringstirred
  8. customThe layers were separated
  9. washthe organic phase was washed thrice with water
  10. customThe organic phase was evaporated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-2c28ce0d3abe4c76b8897459480dc206
Quelldatensatz
uspto-grants-2016_03
Patentnummer
US09273333B2

Notizen zur Reaktion

Wird geladen…